Diaceutics has released research revealing a critical shift in precision medicine. Despite major advances in biomarker testing, nearly two-thirds of eligible patients with advanced non-small cell lung cancer in the U.S. are still not receiving the most appropriate treatment.
Eating creates a temporary metabolic state that influences the function of T cells, according to researchers at the University of Pittsburgh.
